Laboratory Medicine Program

JAK2 (Exon12+Exon14 p.V617F)/CALR(MPD)

Clinical Decription:
Genomic mutations in JAK2 and CALR are common in myeloproliferative neoplasms such as essential thrombocythemia, polycythemia vera and and primary myelofibrosis. Specifically the JAK2 p.Val617Phe variant and insertion and deletions in exon 12 of JAK2 and CALR. Targeted PCR analysis can detect these genomic changes to help with the diagnosis of a myeloproliferative neoplasm.

Method: PCR

Component Tests Used: n/a

Reference Ranges Used:
Reference ranges for this test are not available online. However, they are included in all test results. For more information, please call us.

Specimen Type: peripheral blood (EDTA)
Volume: 5 mL (minimum: 2 mL)

Shipping: room temperature or 4C

Special Instructions: Test will be billed to hospital, laboratory, physician or medical group. See requisitions for the full list of available testing and special instructions.

Testing Schedule(s): Please call

Turnaround Time: None

For more information, call 416.340.5227 or 1.866.865.5227